UPDATE: From 22 May 2026, the NSW Nasal Spray Influenza Vaccination Program has expanded funding for FluMist® to include children aged 2 to 17 years.
In 2026, NSW Health is funding FluMist®, a needle-free nasal spray influenza vaccine for children aged 2 to 17 years (previously only 2–4 years).
It is available at Village Practice alongside the standard injectable flu vaccines.
Due to supply constraints, FluMist® is being offered as part of a time-limited NSW Government program from April to June 2026, or until stock runs out.
Village Practice is now stocking government-funded FluMist®, available free for eligible children aged 2–17 years.
Please note:
FluMist® is approved by the Therapeutic Goods Administration (TGA) for children and adolescents aged 2–17 years.
FluMist® is a needle-free alternative to the standard flu vaccine, administered as a gentle nasal spray by our clinical team during your child’s appointment.
Although relatively new in Australia, FluMist® has been used safely in millions of children internationally for over a decade.
FluMist® contains small amounts of weakened flu viruses that help the body learn to fight infection.
Vaccination works by mimicking a natural infection, stimulating your child’s immune system to build protection against influenza. The nasal spray vaccine is as effective as the injectable flu vaccine and helps reduce the risk of severe illness.
Common side effects are usually mild and short-lived (1–2 days), and may include:
The NSW Government has prioritised children aged 2–4 years because they:
In NSW last year:
Vaccination rates in this age group remain low, and this program aims to improve protection for young children.
Speak with your GP, pharmacist, or Aboriginal Medical Service (AMS) about the most suitable flu vaccine option for your child.
For more informationon the nasal spray flu vaccine (intranasal live attenuated influenza vaccine or LAIV):
© 2026 Village Practice. All rights reserved.
Site by Studio Friday